vs
Side-by-side financial comparison of InflaRx N.V. (IFRX) and ReNew Energy Global plc (RNW). Click either name above to swap in a different company.
InflaRx N.V. is the larger business by last-quarter revenue ($25.7K vs $17.0K, roughly 1.5× ReNew Energy Global plc).
InflaRx N.V. is a clinical-stage biopharmaceutical company specializing in the development of novel anti-inflammatory therapies targeting the complement C5a pathway. Its pipeline addresses unmet medical needs for severe inflammatory diseases including autoimmune and rare inflammatory disorders, serving global patient populations.
ReNew Energy Global plc is an Indian renewable energy company, based in Gurgaon. It is the first Indian renewable energy company to be listed on NASDAQ. ReNew operates more than 150 projects spread across ten states in India.
IFRX vs RNW — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2023
| Metric | | |
|---|---|---|
| Revenue | $25.7K | $17.0K |
| Net Profit | — | — |
| Gross Margin | 98.6% | — |
| Operating Margin | — | — |
| Net Margin | — | — |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $25.7K | — | ||
| Q2 25 | $42.6K | — | ||
| Q2 24 | $6.9K | — | ||
| Q3 22 | — | $17.0K |
| Q3 25 | — | — | ||
| Q2 25 | $-15.6M | — | ||
| Q2 24 | $-15.0M | — | ||
| Q3 22 | — | — |
| Q3 25 | 98.6% | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q3 22 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | -36559.8% | — | ||
| Q2 24 | -217803.1% | — | ||
| Q3 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-33.1M | $4.4K |
| Free Cash FlowOCF − Capex | — | $-23.6K |
| FCF MarginFCF / Revenue | — | -139.0% |
| Capex IntensityCapex / Revenue | — | 164.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-33.1M | — | ||
| Q2 25 | — | — | ||
| Q2 24 | $-29.2M | — | ||
| Q3 22 | — | $4.4K |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q3 22 | — | $-23.6K |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q3 22 | — | -139.0% |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q3 22 | — | 164.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
